PharVision Advisers’s Cisco CSCO Stock Holding History

PharVision Advisers’s Portfolio CSCO Stock Details CSCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,733	Closed	-$398K	–	683
2025 Q2	$398K	Sell	5,733 -3,132	-35%	-$192K	0.57%	29
2025 Q1	$547K	Buy	8,865 +3,383	+62%	+$208K	0.76%	10
2024 Q4	$325K	Buy	+5,482	New	+$313K	0.27%	128

Other funds holding CSCO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PharVision Advisers's CSCO Position: Q3 2025 in Review

PharVision Advisers sold out of Cisco (CSCO) in Q3 2025, closing a stake of 5,733 shares — an estimated $398K sold.

PharVision Advisers first reported a position in CSCO in Q4 2024 and held it in 3 quarters. The position peaked at $547K in Q1 2025. 3,454 funds tracked by Wall St. Rank hold CSCO as of Q3 2025.

PharVision Advisers reported no remaining Cisco position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 5,733 Cisco shares in Q3 2025, an estimated $398K.
PharVision Advisers first reported a position in Cisco in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Cisco position peaked at $547K in Q1 2025.
3,454 funds tracked by Wall St. Rank held Cisco as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.